share_log

HC Wainwright & Co. Initiates Coverage On Instil Bio With Buy Rating, Announces Price Target of $2

HC Wainwright & Co. Initiates Coverage On Instil Bio With Buy Rating, Announces Price Target of $2

HC Wainwright & Co.以買入評級啓動Instil Bio的報道,宣佈目標股價爲2美元
Benzinga ·  2023/06/29 18:10

HC Wainwright & Co. analyst Mitchell Kapoor initiates coverage on Instil Bio (NASDAQ:TIL) with a Buy rating and announces Price Target of $2.

HC Wainwright & Co. 分析師米切爾·卡普爾啓動了對Instil Bio(納斯達克股票代碼:TIL)的報道,評級爲買入,並宣佈目標股價爲2美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論